Crovalimab (PiaSky®) | Package Insert by Hong Kong DengYue Medicine
Crovalimab, marketed under the trade name PiaSky, is a monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria (PNH). It is a complement component 5 (C5) inhibitor. Crovalimab was approved in China in February 2024, in Japan in April 2024, and in the United States in June 2024. The drug was developed and marketed by Roche/Genentech. [PiaSky … Read more